ÂÜÀòÂÒÂ×

Daniel Estandian has worked in the biotechnology field since 2011. Daniel began their career as an Undergraduate Researcher in the Yang Dan Lab in 2011, followed by the Diana Bautista Lab in 2012. In 2013, they moved to the Zachary Knight Lab as a Research Technician, and then to the Edward Boyden Lab as a Graduate Student Researcher in 2016. In 2021, they became the CTO and Co-Founder of Glyphic Biotechnologies.

Daniel Estandian attended the University of California, Berkeley from 2007 to 2012, where they earned a degree in Molecular Biology - Neuroscience. Daniel then pursued a Doctor of Philosophy (PhD) in Brain and Cognitive Sciences at the Massachusetts Institute of Technology, which they completed in 2021.